DAB1

Across TCGA pan-cancer cohorts, DAB1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated DAB1 data layer compared with 25 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher DAB1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated DAB1 expression acts as an unfavorable survival marker, although some lineages such as GBM and PDAC show a favorable association.

GBM and PDAC are the cancer types where DAB1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Tertile	All	0.794	0.270	.006	12	view →
PDAC	DFS	Median	III,IV	0.842	0.246	.021	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

DAB1–GBM (OS)

Open the GBM breakdown →